[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"childhood-asthma-with-acute-exacerbation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:childhood-asthma-with-acute-exacerbation":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100441422","phase-2-azithromycin-treatment-of-hospitalized-children-with-asthmatic-symptoms-100441422",false,"NCT05028153","Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms","Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms: A Double-blinded, Randomized, Controlled Study","COPSACazt","Inclusion Criteria:\n\n* Previous episode(s) with asthma-like symptoms and \u002F medical treatment with SABA as mono-therapy or SABA in combination with ICS and possibly LTRA.\n* The parent\u002Fguardian(s) agrees to admit the child and is willing to follow the procedure of the trial.\n* The child is between 12-71 months old.\n* Fluent Danish skills with parents \u002F guardians.\n\nExclusion Criteria:\n\n* Known allergy to macrolide antibiotics.\n* Known impaired liver function.\n* Known renal impairment.\n* Known with neurological or psychiatric diseases.\n* Known with congenital or documented acquired QT interval.\n* Known for clinically relevant bradycardia, cardiac arrhythmia or severe heart failure.\n* Clinical signs of pneumonia (Objective findings, including severe tachypnoea: respiratory rate (RF)\\> 50 and \u002F or Fever: temperature\\> 39 °C and \u002F or C-reactive protein (CRP)\\> 50).","ALL","12 Months","71 Months",{"count":21,"type":22},320,"ESTIMATED","INTERVENTIONAL",[25],"PHASE2","The purpose of this double-blind, randomized, controlled clinical trial is to investigate the effect of a three-day azithromycin treatment versus placebo treatment in children aged 1-5 years who are hospitalized due to asthma-like symptoms.",[28],"Childhood Asthma With Acute Exacerbation",[30,31,32,33],"Asthma","Infections","Wheeze","Antibiotics","RECRUITING","2025-04-09",{"date":37,"type":38},"2025-04-13","ACTUAL",{"date":40,"type":38},"2022-11-14",{"date":42,"type":22},"2032-11-13",{"name":44,"class":45},"Copenhagen Studies on Asthma in Childhood","OTHER"]